Visfatin reduces gap junction mediated cell-to-cell communication in proximal tubule-derived epithelial cells

Cellular Physiology and Biochemistry

Volumn 32, Issue 5, 2013, Pages 1200-1212

  Hills, Claire E ^a   Kerr, Michael I ^a   Wall, Mark J ^a   Squires, Paul E ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Diabetic Nephropathy; Gap Junctions; Proximal Tubule; Transforming Growth Factor Beta1; Visfatin

Indexed keywords

CONNEXIN 26; CONNEXIN 40; CONNEXIN 43; CRYSTAL VIOLET; LACTATE DEHYDROGENASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA1; GAP JUNCTION PROTEIN; GLUCOSE;

ARTICLE; CELL COMMUNICATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GAP JUNCTION; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; PROTEIN SECRETION; WESTERN BLOTTING; KIDNEY TUBULE CELL; PROTEIN EXPRESSION;

CELL COMMUNICATION; CELL LINE; CELL SURVIVAL; CONNEXIN 43; CONNEXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GAP JUNCTIONS; HUMANS; KIDNEY TUBULES, PROXIMAL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84890673648     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354519     Document Type: Article

References (31)

1. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I: Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;2:1431-1437.
2. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC: Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004;113:1318-1327.
3. Kang YS, Song HK, Lee MH, Ko GJ, Han JY, Han SY, Han KH, Kim HK, Cha DR: Visfatin is upregulated in type-2 diabetic rats and targets renal cells. Kidney Int 2010;78:170-181.
4. Toruner F, Altinova AE, Bukan N, Arslan E, Akbay E, Ersoy R: Plasma visfatin concentrations in subjects with type 1 diabetes mellitus. Horm Res 2009;72:33-37.
5. Akturk M, Altinova AE, Mert I, Buyukkagnici U, Sargin A, Arslan M: Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Invest 2008;31:610-613.
6. Brema I, Hatunic M, Finucane F, Burns N, Nolan JJ, Haider D: Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:600-602.
7. Chan TF, Chen YL, Lee CH, Chou FH, Wu LC, Jong SB: Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 2006; 13:364-367.
8. Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T: Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial Transplant 2008; 23:1621-1627.
9. Song HK, Lee MH, Kim BK, Park YG, Ko GJ, Kang YS, Han JY, Han SY, Han KH, Kim HK, Cha DR: Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 2008;295:F1485-1494.
10. Kanwar YS, Wada J, Sun L: Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 2008:233:4-11.
11. Sharma K and Ziyadeh FN: Hyperglycaemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995;44:1139-1146.
12. Saddi-Rosa P, C Oliveira CSV, Giuffrida FMA, Reis AF: Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr 2010;2:21 doi:10.1186/1758-5996-2-21.
13. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
14. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;12:2495-2508.
15. Hills CE, Squires PE: TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 2010;31:68-74.
16. Hills CE, Squires PE: The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 2011;22:131-139.
17. Hills CE, Siamantouras E, Smith SW, Cockwell P, Liu KK, Squires PE: TGFβ modulates cell-to-cell communication in early epithelial-to- mesenchymal transition. Diabetologia 2012;55:812-824.
18. Caton D, Calabrese A, Mas C, Serre-Beinier V, Wonkam A, Meda P: Beta-cell crosstalk: a further dimension in the stimulus-secretion coupling of glucose-induced insulin release. Diabetes Metab 2002;28:3S45-53.
19. Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM, Roy S: Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Opthalmol Vis Sci 2001;51:3758-3763.
20. Li AF, Roy S: High glucose induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Opthalmol Vis Sci 2009;50:1400-1407.
21. Facemire CS, Gurley SB: Minding the gap: connexin 40 at the heart of renin release. J Am Soc Nephrol 2011;22:985-986.
22. Sato T, Haimovici R, Kao R, Li AF, Roy S: Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes 2002;51:1565-1571.
23. Fernandes R, Girão H, Pereira P: High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem 2004;279:27219-27224.
24. Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J: Connexins and the kidney. Am J Physiol Regul Integr Comp Physiol 2010;298:R1143-1155.
25. Hills CE, Bland R, Bennett J, Ronco PM, Squires PE: TGF-beta1 mediates glucose-evoked up-regulation of connexin-43 cell-to-cell communication in HCD-cells. Cell Physiol Biochem 2009;24:177-186.
26. Hills CE, Bland R, Bennett J, Ronco PM, Squires PE: High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem 2006;18:337-346.
27. Bennett MVL: Physiology of electrotonic junctions. Ann N Y Acad Sci 1966;137:509-539.
28. Nolan MF, Logan SD, Spanswick D: Electrophysiological properties of electrical synapses between rat sympathetic preganglionic neurones in vitro. J Physiol 1999;519:753-764.
29. Hills CE, Willars GB, Brunskill NJ: Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways. Mol Endocrinol 2010;24:822-831.
30. Hills CE, Al-Rasheed N, Al-Rasheed N, Willars GB, Brunskill NJ: C-peptide reverses TGF-beta-1 induced changes in renal proximal tubular cells: implications for treatment of DN. Am J Physiol 2009;296:F614-621.
31. McGee KC, Harte AL, da Silva NF, Al-Daghri N, Creely SJ, Kusminski CM, Tripathi G, Levick PL, Khanolkar M, Evans M, Chittari MV, Patel V, Kumar S, McTernan PG: Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes. PLoS ONE 2011;6:e20287. doi:10.1371/journal.pone.0020287.